Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21181243 | 0.98 | KDM4E (0.34) | KDM4EATML3MBTL1CHRNB4CHRNA3 | |
| SCHEMBL13616270 | 0.90 | ATM (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL21388343 | 0.88 | — | — | |
| SCHEMBL14141240 | 0.88 | ATM (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL25779686 | 0.85 | ATM (0.40) | KDM4EATML3MBTL1 | |
| SCHEMBL14046737 | 0.85 | CHRNB1 (0.31) | CHRNB4CHRNA3 | |
| SCHEMBL16588606 | 0.85 | ATM (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL26752787 | 0.85 | ATM (0.37) | KDM4EATML3MBTL1 | |
| SCHEMBL5028260 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1 | |
| SCHEMBL21319931 | 0.84 | KDM4E (0.30) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11469381-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-10-11 | — | — | US | disclosed |
| US-20190312209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11469381-B2 | Condensed cyclic compound and organic light-emitting device including the same | ARL1, CCNL2, CRY1 | KDM4E 3923/4885ATM 723/4885L3MBTL1 344/4885 |
| US-20190312209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ARL1, CCNL2, CRY1 | KDM4E 3923/4885ATM 723/4885L3MBTL1 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.